Market Research Future published a cooked research report on “Radiopharmaceutical Market Research Report – By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
Avail Exclusive Sample Copy at https://www.marketresearchfuture.com/sample_request/1650
Radiopharmaceutical Market Overview:
The Global Radiopharmaceutical Market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023. As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person’s specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.
Jubilant Life Sciences
Sun Pharmaceutical Industries
Radiopharmaceutical Market – Segmentation:
The Global Radiopharmaceutical Market is segmented based on type, type of test, application, route of administration, and end user.
By type, the market for radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. The diagnostic type radiopharmaceutical segment is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. The therapeutic type radiopharmaceutical segment is further sub-segmented into beta emitters, alpha emitters, brachytherapy. The SPECT radiopharmaceutical segment is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. The PET radiopharmaceutical segment is further sub-segmented into F-18, Rubidium-82, and others. The Beta emitters segment is further sub-segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. The brachytherapy segment is sub-segmented into Iodine-125, Iridium-192, Cesium-131, and others.
By type of test, the market is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. The bone scan segment is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. The Myocardial Perfusion Scan segment is further sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan segment is further sub-segmented into Xenon-133, Krypton-81m, and others. The White blood cell Scan segment is sub-segmented into Indium-111 and others.
Radiopharmaceutical Market – Regional Overview:
The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.
Major TOC of Radiopharmaceutical Market Research Report – Forecast to 2023:
1 Report Prologue
2 Executive Summary
3 Market Introduction
4 Research Methodology
5 Market Dynamics
6 Market Factor Analysis
7 Global Radiopharmaceutical Market, by Type
8 Global Radiopharmaceuticals Market, by Type of Test
9 Global Radiopharmaceutical Market, by Application
10 Global Radiopharmaceutical Market, by Route of Administration
11 Global Radiopharmaceutical Market, by End-User
12 Global Radiopharmaceutical Market, by Region
13 Competitive Landscape
14 Company Profile
Avail Stunning Discount at https://www.marketresearchfuture.com/sample_request/1650
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312